Jaguar Health (JAGX) Treasury Shares (2014 - 2026)
Jaguar Health's (JAGX) quarterly Treasury Shares came in at $1.2 million in Q1 2026, up 1254372.73% year-on-year from N/an in Q1 2025, and up 14670.79% on a QoQ basis from $8408.0 in Q3 2025.
Jaguar Health (JAGX) Treasury Shares (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 13 years of Treasury Shares data on file, last reported at $1.2 million in Q1 2026.
- On a quarterly basis, Treasury Shares rose 1254372.73% year-over-year to $1.2 million in Q1 2026; TTM through Mar 2026 was $1.2 million, a 1254372.73% increase from a year earlier, with the FY2025 full-year figure at $5020.0, up 4970.71% from the prior year.
- Treasury Shares for Q1 2026 stood at $1.2 million, up from $8408.0 in the prior quarter.
- Over the last five years, Treasury Shares for JAGX reached as high as $3.5 million in Q1 2022 and fell as low as $6.0 in Q4 2024.
- Historically, Treasury Shares has averaged $725061.1 across 5 years, with a median of $9421.0 in 2025.
- Across the five-year window, Treasury Shares slumped 99.79% in 2024 and soared 1254372.73% in 2026, its largest moves.
- Year by year, Treasury Shares stood at $22.0 in 2022, then surged by 8072.73% to $1798.0 in 2023, then slumped by 99.67% to $6.0 in 2024, then jumped by 140033.33% to $8408.0 in 2025, then jumped by 14670.79% to $1.2 million in 2026.
- Per Business Quant data, the three most recent Treasury Shares figures were $1.2 million in Q1 2026, $8408.0 in Q3 2025, and $10434.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,774.59 Bn | 1,774.53 Bn | - | 259,453.57 |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 3 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn | - |
| 4 | Vertex Pharmaceuticals | 123.91 Bn | 116.66 Bn | 2.59 Bn | - |
| 5 | Regeneron Pharmaceuticals | 71.79 Bn | 63.04 Bn | 3.31 Bn | 34.70 Mn |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - | - |
| 7 | Argenx Se | 54.75 Bn | 49.57 Bn | 1.41 Bn | - |
| 8 | Alnylam Pharmaceuticals | 38.10 Bn | 35.10 Bn | 959.66 Mn | - |
| 9 | Revolution Medicines | 36.11 Bn | 36.11 Bn | - | 5.14 Mn |
| 10 | Jaguar Health | 509,443.80 | -9.55 Mn | 19.11 Mn | 1.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.24 Mn |
| Mar 31, 2026 | 1.24 Mn |
| Sep 30, 2025 | 8,408.00 |
| Sep 30, 2025 | 8,408.00 |
| Jun 30, 2025 | 10,434.00 |
| Jun 30, 2025 | 10,434.00 |
| Mar 31, 2025 | 99.00 |
| Mar 31, 2025 | 99.00 |
| Dec 31, 2024 | 6.00 |
| Dec 31, 2024 | 6.00 |
| Sep 30, 2024 | 99.00 |
| Sep 30, 2024 | 99.00 |
| Jun 30, 2024 | 99.00 |
| Jun 30, 2024 | 99.00 |
| Mar 31, 2024 | 99.00 |
| Mar 31, 2024 | 99.00 |
| Dec 31, 2023 | 1,798.00 |
| Dec 31, 2023 | 1,798.00 |
| Sep 30, 2023 | 35,278.00 |
| Sep 30, 2023 | 35,278.00 |